| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 01/30/2003 | US20030022914 Nitric oxide synthase inhibitors |
| 01/30/2003 | US20030022893 Hydroxamic and carboxylic acid derivatives |
| 01/30/2003 | US20030022890 Heterocyclic dihydropyrimidine compounds |
| 01/30/2003 | US20030022885 Pyrazole compounds useful as protein kinase inhibitors |
| 01/30/2003 | US20030022852 Biodegradable immunomodulatory formulations and methods for use thereof |
| 01/30/2003 | US20030022848 Antisense oligonucleotide modulation of tumor necrosis factor-alpha (TNF-alpha) expression |
| 01/30/2003 | US20030022836 Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules |
| 01/30/2003 | US20030022819 Administering to an animal an angiogenic amount of a hedgehog polypeptide or agonist to promote angiogenesis |
| 01/30/2003 | US20030022172 Polyamide nucleic acid derivatives and agents and processes for preparing them |
| 01/30/2003 | US20030021857 Plant extracts; viricides, blood flow, alopecia |
| 01/30/2003 | US20030021855 Topical applying |
| 01/30/2003 | US20030021854 Nanocrystal microbiocide metal |
| 01/30/2003 | US20030021833 Administering selegiline, or metabolite thereof |
| 01/30/2003 | US20030021832 Wound healing agents on backing |
| 01/30/2003 | US20030021777 Product comprising bound fibrinogen and thrombin for use in wound therapy or surgical repair |
| 01/30/2003 | US20030021776 Regulation of angiogenesis with zinc finger proteins |
| 01/30/2003 | US20030021769 Use of strains of parapoxvirus ovis for producing antiviral medicaments and medicaments against cancer |
| 01/30/2003 | DE19943553C2 Zusammensetzung, insbesondere Pflegebalsam Composition, particularly balm |
| 01/30/2003 | CA2733813A1 Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of clyclooxygenase-2 |
| 01/30/2003 | CA2682251A1 A synergistic pharmaceutical combination for the prevention or treatment of diabetes |
| 01/30/2003 | CA2454419A1 Invasion complex and methods of targeting |
| 01/30/2003 | CA2454332A1 Process for the preparation of acitretin |
| 01/30/2003 | CA2454059A1 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
| 01/30/2003 | CA2453967A1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/30/2003 | CA2453965A1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/30/2003 | CA2453765A1 Polysaccharidic esters of retinoic acid |
| 01/30/2003 | CA2453636A1 Polypyrroles as agents for treating cancer, treating viral diseases and causing immunosuppression |
| 01/30/2003 | CA2453613A1 Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors |
| 01/30/2003 | CA2453602A1 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors |
| 01/30/2003 | CA2453473A1 Water-free ubichinon concentrate |
| 01/30/2003 | CA2453294A1 Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents |
| 01/30/2003 | CA2452678A1 Combination of eplerenone and an hmg coa reductase inhibitor |
| 01/30/2003 | CA2452541A1 (pyridinyl and pyrimidyl) trienoic acid derivatives as retinoid x receptor modulators |
| 01/30/2003 | CA2452357A1 Pharmaceutical formulation containing an ltb4 antagonist |
| 01/30/2003 | CA2452009A1 Chemical compounds |
| 01/30/2003 | CA2451530A1 Chemical compounds |
| 01/30/2003 | CA2450437A1 1-phenylsulphonyl-1,3-dihydro-2h-indol-2-one derivatives, their preparation and their therapeutic application |
| 01/30/2003 | CA2417955A1 Quinazolines, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
| 01/29/2003 | EP1279729A1 Factors participating in degranulation of mast cells, dnas encoding the same, method of screening inhibitors of these factors and the inhibitors |
| 01/29/2003 | EP1279666A1 1-diphenylmethyl-pyrazole derivatives as opioid receptor ligands |
| 01/29/2003 | EP1279404A1 Use of HIV-1 tat, fragments or derivatives thereof, to target or to activate antigen-presenting cells, to deliver cargo molecules for vaccination or to treat other diseases |
| 01/29/2003 | EP1279402A1 Coated granules of allylamine-or benzylamine-anti-mycotics, process for preparation thereof and orodispersible tablets containing said coated granules |
| 01/29/2003 | EP1279400A1 Modifying the fatty acid composition of cell membranes of organs and tissues |
| 01/29/2003 | EP1279332A2 Transgenic non-human mammal |
| 01/29/2003 | EP1278869A2 Proteases |
| 01/29/2003 | EP1278854A2 Compositions and methods for the therapy and diagnosis of acne vulgaris |
| 01/29/2003 | EP1278846A2 Cytoskeleton-associated proteins |
| 01/29/2003 | EP1278826A1 Novel proteins |
| 01/29/2003 | EP1278778A2 Modified peptides, comprising an fc domain, as therapeutic agents |
| 01/29/2003 | EP1278770A1 Human wingless-like gene |
| 01/29/2003 | EP1278767A1 Albumin fusion proteins |
| 01/29/2003 | EP1278763A1 3-nitrogen-6,7-dioxygen steroids and uses related thereto |
| 01/29/2003 | EP1278750A1 Imidazopyrimidine derivatives and triazolopyrimidine derivatives |
| 01/29/2003 | EP1278749A1 USE OF 5-THIO-, SULFINYL- AND SULFONYLPYRAZOLO 3,4-b]-PYRIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS |
| 01/29/2003 | EP1278748A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 01/29/2003 | EP1278734A2 Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore |
| 01/29/2003 | EP1278732A1 1-aroyl-piperidinyl benzamidines |
| 01/29/2003 | EP1278719A1 Naphthamide neurokinin antagonists for use as medicaments |
| 01/29/2003 | EP1278716A1 Cyclohexylamine derivative as subtype selective nmda receptor antagonists |
| 01/29/2003 | EP1278574A2 Topical composition for the treatment of psoriasis and related skin disorders |
| 01/29/2003 | EP1278544A2 Albumin fusion proteins |
| 01/29/2003 | EP1278532A1 Plant extract of the olea europaea species as no-synthase inhibitor and uses |
| 01/29/2003 | EP1278528A1 Nucleoside analogs with carboxamidine-modified bicyclic base |
| 01/29/2003 | EP1278517A2 Methods for improving size and appearance of a wound |
| 01/29/2003 | EP1278512A2 Cationic diagnostic, imaging and therapeutic agents associated with activated vascular sites |
| 01/29/2003 | EP1278509A1 Lipochroman-6 as no-synthase inhibitor and uses |
| 01/29/2003 | EP1278508A1 Plant extract of the species i vitis vinifera /i as no-synthase inhibitor and uses |
| 01/29/2003 | EP1278502A2 Protease inhibitors |
| 01/29/2003 | EP1265570A4 Soluble keratin peptide |
| 01/29/2003 | EP1104425B1 Novel thiazolopyrimidine compounds |
| 01/29/2003 | EP1030836B1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 01/29/2003 | EP0832081B1 Bicyclic-aromatic compounds |
| 01/29/2003 | EP0572560B1 Use of pharmaceutical compounds in the treatment of symptoms of disorders related to neurological diseases and etiologically related symptomology |
| 01/29/2003 | CN1394206A Novel vitamin D analogues |
| 01/29/2003 | CN1394201A Substituted glutarimides and use thereof IL-12 production inhibitors |
| 01/29/2003 | CN1394138A Hair growth stimulant |
| 01/29/2003 | CN1393253A Yulie ointment |
| 01/29/2003 | CN1393252A Ointment for treating burn and its preparing process |
| 01/29/2003 | CN1393247A Chinese-medicinal ointment for treating burn and scald |
| 01/29/2003 | CN1393240A Antibacterial and anti-inflammatory medicine and its preparing process |
| 01/29/2003 | CN1393237A Process for preparing liniment to treat leukoderma |
| 01/29/2003 | CN1393234A 'Jingema' honeyed cream for antipyresis and detoxication |
| 01/29/2003 | CN1393230A Prescription for composite medicinal film prepared from chitosan and Chinese-medicinal materials |
| 01/29/2003 | CN1393221A Liquid medicine for treating acne |
| 01/29/2003 | CN1393214A Face-beautifying and spot-removing cream and its preparing process |
| 01/29/2003 | CN1393178A Nutritive instant food for removing senile plaque |
| 01/29/2003 | CN1099880C Paint liquid medicine for skin recovery of burn and scald and preparation process thereof |
| 01/29/2003 | CN1099876C Medicine for curing psoriasis |
| 01/29/2003 | CN1099875C Dermatosis treating medicine |
| 01/29/2003 | CN1099874C Acne treating medicine |
| 01/28/2003 | WO2002018372A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof |
| 01/28/2003 | US6512023 An adhesive composition includes a polymerizable adhesive monomer, at least one vapor phase stabilizer, and at least one liquid phase stabilizer. The combination of at least one vapor phase stabilizer and at least one liquid phase |
| 01/28/2003 | US6511997 For treatment of a disease associated with tumor necrosis factor alpha, interleukin 1, interleukin 6 or cyclooxygenase II; such as irritable bowel disease |
| 01/28/2003 | US6511979 Methods for treating conditions modulated by lactosylceramide |
| 01/28/2003 | US6511684 Cosmetics or dermitologicals from such as inga bourgoni, goupia glabra or eperua falcate for skin, mucous membranes and/or epithelium |
| 01/28/2003 | US6511670 (poly)thiaalkynoic compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 01/28/2003 | US6511659 Treatment of alopecia, cosmetics |
| 01/28/2003 | US6511656 Compositions for coloring the skin comprising at least one flavylium salt which is unsubstituted in position 3 and at least one organomodified silicone |
| 01/28/2003 | CA2318432C The use of isolated domains of type iv collagen to modify cell and tissue interactions |
| 01/28/2003 | CA2297560C Nanoemulsion based alkoxyle alkenyle succinates or alkoxyle glucose alkenyle succinates and it's use in cosmetics, dermatological, ophtalmological and/or pharmaceutical |